Compete Trial - Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide vs. Everolimus in progressive GEP-NET (ID 1568)

Speakers
Session Name
MW-2 - SNMMI/ACNM - Poster

Previous Eposter
Clinical production of 1-(2-[18F]fluoroethyl)-L-tryptophan for imaging of tryptophan metabolism (ID 1551)

Next Eposters
Correlation Attenuation and Regression Dilution in Radionuclide Angiography (ID 1573)
Correlation of blood pool and liver uptake values with radionuclide extravasation in FDG PET (ID 1580)
Deep Learning Enabled Automated Lesion Detection in 18F-DCFPyL PET/CT (ID 1564)
Differentiation of HPV status in head and neck squamous cell cancer patients based on 18F-FDG PET/CT uptake in primary tumor and regional lymph nodes - results from a single-center study. (ID 1561)
Evaluation of organ and lesion repeatability of 68Ga-HBED-PSMA PET (ID 1581)
Introducing Lutathera Therapy in a Community Practice (ID 1579)
No Eposter Preview Available
Metrics to evaluate PET response to therapy based on 3D. analysis (ID 1575)
Motion estimation and motion-corrected reconstruction with inverse Radon transformation using deep learning (ID 1566)
Myocardial Perfusion Scan as a Screening Tool for Obstructive Sleep Apnea. (ID 1550)
Novel Method to Calculate Equivalent Dose to Tissue in Cases of Radiopharmaceutical Extravasation (ID 1570)